| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.87B | -14.8% |
| Cost of Revenue | $1.06B | -11.6% |
| Gross Profit | $814.4M | -18.6% |
| R&D Expense | $16.6M | -1.8% |
| SG&A Expense | $660.7M | +12.5% |
| Operating Income | $11.1M | -95.2% |
| Interest Expense | $175.3M | +64.3% |
| Pre-tax Income | -$297.6M | -425.9% |
| Income Tax | -$945K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.0M | +13.9% |
| Accounts Receivable | $202.9M | -54.3% |
| Inventory | $404.1M | -58.0% |
| Current Assets | $845.2M | -46.1% |
| Total Assets | $3.04B | -25.0% |
| Current Liabilities | $349.6M | -9.1% |
| Long-term Debt | $1.88B | +5.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | +89.9% |
| Capital Expenditures | $44.3M | -21.8% |
| Investing Cash Flow | -$42.6M | +89.9% |
| Financing Cash Flow | $55.1M | -45.2% |
| Free Cash Flow | -$51.1M | +58.9% |
| -101.9% |
| Net Income | -$226.4M | -1867.8% |
| EPS (Diluted) | -$3.59 | -214.9% |
| Total Liabilities |
| $2.47B |
| -1.0% |
| Stockholders' Equity | $442.0M | -65.9% |